Merger Model Accretion Dilution Analysis: How to Read the EPS Bridge

Accretion/dilution analysis is the merger-model output that tells you, in one number, whether a deal makes the acquirer's shareholders richer or poorer on a per-share basis in Year 1. It compares pro forma combined EPS to the acquirer's standalone EPS, and it walks from one to the other through an "EPS bridge" that isolates the deal's real economic drivers: added net income from the target, financing costs, synergies, and new shares issued. If you can read the bridge, you can tell a $28 billion strategic acquisition from a $28 billion ego trip.

Public acquirers live and die by this number. When Cisco announced its $28 billion cash acquisition of Splunk in September 2023, the deck told investors the deal would be non-GAAP EPS accretive in fiscal year 2026 — not on day one, but soon enough to defend the price tag. When ExxonMobil announced its $59.5 billion all-stock deal for Pioneer Natural Resources on October 11, 2023, the press release led with the claim that the merger was "accretive immediately" and "highly accretive mid- to long-term" to EPS. That phrasing is not marketing. It is a specific claim produced by a specific model, and equity research desks tear it apart within minutes of the announcement.

What the merger model actually computes

Every accretion/dilution model is the same three-line calculation dressed up in different clothes:

Pro forma net income = Acquirer standalone net income + Target standalone net income + After-tax synergies − After-tax incremental interest expense − After-tax new intangible amortization
Pro forma diluted share count = Acquirer diluted shares + New shares issued to fund the deal (zero in an all-cash deal)
Pro forma EPS = Pro forma net income ÷ Pro forma diluted shares

Accretion or dilution is then simply Pro forma EPS ÷ Standalone EPS − 1. If the acquirer's standalone EPS is $1.00 and pro forma EPS is $1.10, the deal is 10% accretive. If pro forma EPS is $0.92, it is 8% dilutive. The mechanics are trivial; the judgment sits inside each line item.

Takeaway: before you touch a spreadsheet, write the three-line calculation on paper. Every cell in a 300-tab merger model resolves to one of those three numbers.

How to read the EPS bridge, line by line

The EPS bridge is a waterfall chart that starts at standalone EPS on the left and ends at pro forma EPS on the right. Between those two bars sit five drivers, in this order:

Target net income contribution. This is always positive (assuming the target is profitable). It is the "raw fuel" of the deal — the acquirer is buying earnings.
After-tax cost synergies. When Morgan Stanley acquired E*TRADE in an all-stock deal that closed in October 2020, management guided to roughly $400 million in annual expense synergies from consolidating duplicative platforms and infrastructure. In your bridge, those synergies flow in at the marginal tax rate, so a $400 million pre-tax synergy at a 25% tax rate is $300 million of added net income.
Incremental interest expense (after-tax). If the deal is funded with new debt, model the coupon on the new notes, tax-affect it, and subtract. This is the single largest reason cash deals turn dilutive in a high-rate environment — the "cost of cash" is no longer near zero.
New intangible amortization (after-tax). Purchase accounting under ASC 805 forces the acquirer to allocate the purchase premium to identifiable intangibles (customer relationships, developed technology, trade names) and amortize them over their useful lives. That amortization is a non-cash charge but a real GAAP expense — which is why most acquirers publish accretion on a non-GAAP basis that adds it back. Cisco's Splunk guidance was explicitly non-GAAP for exactly this reason.
New shares issued. In an all-stock or mixed-consideration deal, the acquirer prints shares. Even if pro forma net income rises, dividing by a bigger share count can push EPS below standalone. This is where ExxonMobil's 2.3234 exchange ratio for Pioneer shares matters — every share of the target consumed 2.3234 shares of dilution.

Takeaway: when you look at any bridge, immediately identify which two bars are the biggest. Nine times out of ten, the deal thesis is a fight between "target earnings + synergies" on the accretive side and "new shares OR new interest" on the dilutive side.

The rules of thumb that pass the sanity check

Before you build a 40-tab model, use the shortcuts every M&A banker keeps in their head. Breaking Into Wall Street's merger model training summarizes them the same way most bulge-bracket training programs do:

All-cash deal: accretive if the target's after-tax yield (target net income ÷ purchase equity value) exceeds the after-tax cost of new debt used to fund it.
All-stock deal: accretive if the acquirer's P/E is higher than the target's P/E on the offer price. A high-P/E acquirer buying a low-P/E target with stock is almost always accretive on paper, which is exactly why cheap-stock buyers get suspicious of the "acquisition machine" narrative.
All-debt deal at a 5% after-tax cost: accretive if the target's P/E is below 20x (the reciprocal of 5%). At a 7% after-tax cost, the P/E threshold drops to about 14x.

These are back-of-the-envelope checks, not conclusions. But if the shortcut says "should be dilutive" and your model says "8% accretive," a formula is wrong somewhere — usually a hardcoded synergy or a missing interest tick.

Takeaway: compute the shortcut answer first, then build the full model, then reconcile the two. If they disagree by more than a couple of hundred basis points, hunt down the difference before you send anything to a committee.

Real 2025 disclosures: what the pros actually publish

The clearest way to calibrate your own model is to read what public acquirers put in their proxy statements. Two 2025 filings show the range:

Bank First Corp's 2025 acquisition of Centre 1 Bancorp (announced April 2025 in an 8-K on file with the SEC) projected 33.9% EPS accretion in 2026 and 31.1% in 2027, with tangible book value dilution of 5.1% at closing. That combination — big EPS accretion, real TBV dilution up front — is the classic bank-M&A pattern, and the earnback period on TBV dilution is the first question every bank investor asks.
Redwire Corp's 2025 acquisition of Edge Autonomy disclosed in its PREM14A that Roth Capital's analysis expected the transaction to be accretive to Redwire's EPS by $0.28 per share on a pro forma basis for calendar year 2025.

Notice what these disclosures share: a specific EPS delta, a specific year, and a named financial advisor whose fairness opinion stands behind the math. When you build your own model, mimic that discipline. "Accretive" without a year attached is meaningless — it is trivially easy to make any deal accretive in Year 5 by ramping synergies aggressively enough.

Takeaway: quote accretion by fiscal year (Year 1, Year 2, Year 3) and always show the synergy phase-in schedule underneath. A deal that is 2% dilutive in Year 1 and 15% accretive in Year 3 is a fundamentally different story than one that is 5% accretive in Year 1 and flat thereafter.

Where merger models mislead — and how to stress-test yours

Accretion/dilution analysis is one input to a capital-allocation decision, not the decision itself. Wall Street Prep's merger model curriculum makes the point directly: a deal can be initially dilutive but strategically correct if synergies are real and the target unlocks defensible growth. Conversely, a deal can be "accretive" on paper and still destroy value if the financing structure hides risk or the synergies never arrive.

Run these four stress tests before you sign off on any bridge:

Zero-synergy case. Rebuild pro forma EPS with cost synergies set to zero and revenue synergies set to zero. If the deal is materially dilutive without synergies, you are underwriting execution, not economics.
Rate-shock case. Push the new-debt coupon up 200 basis points. Cash deals that were marginally accretive in a 4% rate environment can flip dilutive in a 6% environment.
Amortization schedule sensitivity. Vary the useful lives of the acquired intangibles by ±3 years. This is a purchase-accounting judgment call, not a fact, and it can swing GAAP accretion by 100–200 basis points.
Share-price sensitivity in a stock deal. The exchange ratio is fixed at signing, but the value of the consideration moves with the acquirer's stock. If your stock is down 20% at closing, is the deal still economically the same? For ExxonMobil-Pioneer, a fixed 2.3234 ratio meant Pioneer holders bore the price risk between signing and close.

Takeaway: a model that only shows the base case is a marketing document. A model that shows a zero-synergy case and a rate-shock case is a decision document.

Build your bridge once, use it every deal

The mechanics of accretion/dilution analysis do not change from deal to deal. The purchase-price inputs change, the financing structure changes, the synergy schedule changes — but the calculation chain is identical. Which is why every M&A group, corporate development team, and buy-side analyst maintains a reusable merger model template with the EPS bridge already wired up: standalone EPS on the left, five driver bars in the middle, pro forma EPS on the right, with sensitivity tables on price, synergies, and financing mix living one tab away.

If you are building that template from scratch each time you look at a deal, you are burning hours on plumbing you should have finished once. A well-built merger model with a ready-to-run EPS bridge, purchase-price allocation waterfall, synergy phase-in schedule, and rate-shock sensitivity turns a two-week modeling exercise into a two-hour customization job — and it forces the discipline of naming the year, the synergy assumption, and the stress case every single time.